Hesse Michael, Grund Christine, Herrmann Harald, Bröhl Dominique, Franz Thomas, Omary M Bishr, Magin Thomas M
Institut für Physiologische Chemie, Abteilung für Zellbiochemie, Bonner Forum Biomedizin and LIMES, Rheinische Friedrich-Wilhelms-Universitaet, Nussallee 11, 53115 Bonn, Germany.
Exp Cell Res. 2007 Aug 15;313(14):3127-40. doi: 10.1016/j.yexcr.2007.05.019. Epub 2007 May 25.
Mutations in genes encoding epidermal keratins cause skin disorders, while those in internal epithelial keratins, such as K8 and K18, are risk factors for liver diseases. The effect of dominant mutations in K8 or K18 during embryonic development and tissue homeostasis has not been examined so far. Here we demonstrate that the dominant mutation hK18 R89C, that is highly similar to hK14 R125C, causing EBS in humans, leads to cell type-specific lethality in mice, depending on the ratio of mutant to endogenous keratins. Mice expressing hK18 R89C in the absence of endogenous K19 and K18 died at mid-gestation from defects in trophoblast giant cells, accompanied by haematomas. A single, endogenous K18 allele rescued embryonic lethality but caused aggregation of keratins in all adult internal epithelia, surprisingly without spontaneous cell fragility. Closer analysis revealed that both filaments and aggregates coexisted in the same cell, depending on the ratio of mutant to endogenous keratins. Our results demonstrate that balanced overexpression of a wild-type keratin rescued the lethal consequences of a dominant-negative mutation. This has important implications for therapy approaches of keratinopathies, suggesting that suppressing the mutant allele is not necessary in vivo.
编码表皮角蛋白的基因突变会引发皮肤疾病,而编码内部上皮角蛋白(如K8和K18)的基因突变则是肝脏疾病的风险因素。迄今为止,尚未研究K8或K18中的显性突变在胚胎发育和组织稳态过程中的影响。在此,我们证明,与导致人类单纯性大疱性表皮松解症(EBS)的hK14 R125C高度相似的显性突变hK18 R89C,根据突变型与内源性角蛋白的比例,会导致小鼠出现细胞类型特异性致死现象。在缺乏内源性K19和K18的情况下表达hK18 R89C的小鼠在妊娠中期因滋养层巨细胞缺陷而死亡,并伴有血肿。单个内源性K18等位基因挽救了胚胎致死性,但导致所有成年内部上皮细胞中的角蛋白聚集,令人惊讶的是,并未出现自发性细胞脆性增加的情况。进一步分析表明,细丝和聚集体在同一细胞中共存,这取决于突变型与内源性角蛋白的比例。我们的结果表明,野生型角蛋白的平衡过表达挽救了显性负性突变的致死后果。这对角蛋白病的治疗方法具有重要意义,表明在体内并非必须抑制突变等位基因。